Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCC
(MedPage Today) -- More than 90% of patients with locally advanced basal cell carcinoma (BCC) of the head and neck achieved locoregional control (LRC) with vismodegib (Erivedge) and radiation therapy (RT), a small clinical trial showed.
LRC at... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - March 1, 2024 Category: Radiology Source Type: news
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
FORT LEE, N.J., March 1, 2024 /PRNewswire/ -- Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 1, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
The Need for Better Minority Enrollment in Multiple Myeloma Clinical Trials
African Americans are more likely to develop multiple myeloma but are underrepresented in clinical trials. Here’s why and what can be done about it. (Source: WebMD Health)
Source: WebMD Health - March 1, 2024 Category: Consumer Health News Source Type: news
Xtalks Announces its Life Science Webinar Calendar for March 2024
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, fundamental research, laboratory technology, medical device, pharmaceutical, pharma manufacturing & supply... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 1, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news
ACR chief research officer talks importance of diversity in research
Black History Month may be ending, but understading the importance and triumphs of diversity doesn’t have to end with February’s passing.
In radiology research, the age of precision medicine means better understanding different challenges that unique patient populations face. And researchers have called for more diversity in clinical trials to address these challenges.
Etta Pisano, MD, spoke with AuntMinnie.com about challenges, successful recruitment strategies, and the importance of diversity in research trials. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 1, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Imaging Leaders Source Type: news
Viking Therapeutics stock has wild week after weight-loss drug results impress Wall Street
Viking Therapeutics stock (VKTX) has been on a tear this week after it announced the phase II clinical trial results for a new experimental drug in the booming weight-loss industry. On Tuesday, shares of Viking Therapeutics more than doubled, soaring over 120% to $85 as Wall Street cheered the…#vikingtherapeutics #novonordisk #wegovy #elililly #lly #justinzelin #yahoofinancelive #lilly #williamblair #glp (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news
R.S.V. Vaccines May Slightly Increase Risk of Rare Neurological Condition
Federal health officials presented data hinting at a link to Guillain-Barr é syndrome, but said the connection was still uncertain. (Source: NYT Health)
Source: NYT Health - February 29, 2024 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Disease Rates Vaccination and Immunization Guillain-Barre Syndrome Respiratory Syncytial Virus (RSV) Elderly Statistics Drugs (Pharmaceuticals) Clinical Trials Source Type: news
The AI Revolution in Clinical Research: Next-Gen Precision Patient Matching, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how to use AI to mine structured and unstructured electronic medical record (EMR) data to precisely find patients for clinical trials and real-world evidence studies. The featured speakers will discuss case studies on precisely identifying patients with chronic... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 29, 2024 Category: Pharmaceuticals Source Type: news
Using Marijuana to Ease Stress? Focus on CBD, not THC
THURSDAY, Feb. 29, 2024 -- Folks hoping to quell their anxiety would do best to use cannabis products that don’t get them high, a new clinical trial has found.
The non-intoxicating marijuana compound CBD appears to help manage anxiety better... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 29, 2024 Category: General Medicine Source Type: news
Kimmtrak Tebentafusp Sales Increase By 64% In 2023
In the battle against melanoma, Kimmtrak has emerged as a groundbreaking treatment that offers an innovative approach of treatment with significant commercial potential. Although Kimmtrak is currently only approved for the treatment of uveal melanoma, clinical trials are being conducted to…#tebentafusp #immunocore (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news
Pfizer announces positive top-line data for full season two efficacy of ABRYSVO ® for RSV in older adults
Pfizer Inc. (NYSE: PFE) today announced top-line ABRYSVO® vaccine efficacy and safety data for respiratory syncytial virus (RSV) in adults 60 years of age and older following a second season in the Northern and Southern Hemispheres from the ongoing pivotal Phase 3 clinical trial (NCT05035212) RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease). (Source: World Pharma News)
Source: World Pharma News - February 29, 2024 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
Drug Development Considerations for Empiric Antibacterial Therapy in Febrile Neutropenic Patients - 04/23/2024
The purpose of the public workshop is to discuss clinical trial design and other considerations related to the development of antibacterial drug products for treatment of febrile neutropenia (FN). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 28, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Cancer Hope Network Announces One-On-One Peer Mentorship Collaboration with Lazarex Cancer Foundation
New collaboration helps address barriers to clinical trials participation, expands resources to patients and caregivers CHESTER, N.J., Feb. 28, 2024 /PRNewswire-PRWeb/ -- Cancer Hope Network and Lazarex Cancer Foundation announced today a new collaboration that will expand patient and... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 28, 2024 Category: Pharmaceuticals Tags: NPT Source Type: news
New Trials in Leukemia/Lymphoma: Could Your Patient Benefit? New Trials in Leukemia/Lymphoma: Could Your Patient Benefit?
Perhaps one of your patients would benefit from enrolling in a new clinical trial in leukemia or lymphoma?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 28, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Mayo Clinic's strong performance in 2023 ignites healthcare transformation
ROCHESTER, Minn. — Fueled by strong performance across all activities in 2023, Mayo Clinic achieved remarkable progress toward its goal of transforming healthcare for people everywhere by making critical investments in valued staff, innovative facilities and pioneering digital technologies. Key performance highlig hts include: Industry-leading rankings from Newsweek and U.S. News& World Report. A record high of more than 2,500 active clinical trials for patients seeking new cures. Delivering high-quality, convenient care to patients through… (Source: Mayo Clinic Arizona News)
Source: Mayo Clinic Arizona News - February 28, 2024 Category: Hospital Management Source Type: news
